Hiray Pharmaceutical – API CDMO and Antiviral API R&D Center

APIs are in the upper reaches of the pharmaceutical industry chain and are the basis for ensuring the supply of drugs and meeting the people's demand for drugs. In recent years, in the context of favorable pharmaceutical policies and the advent of imitation, the domestic API industry is also facing a new round of opportunities. With the volume of centralized purchase, consistency evaluation, correlation review, environmental protection pressure. Under the influence of these policies, the industry concentration is getting higher and higher. "Environmental protection, quality, and cost, these three aspects are factors that must be considered for the sustainable development of API companies. In this context, Hanrui Pharmaceutical (Jingmen) Co., Ltd. Was established.

Hiray pharmaceutical（Jingmen）Co.,LTD, located in the chemical recycling industrial park of Jingmen City, Hubei Province, was founded in January 2019. Our business covers the R&D, production and sales of chemical APIs and pharmaceutical intermediates. We design and build a modern high-end API production and research site in strict accordance with the US-FDA, EU and China GMP standards.

Our Tenet: Innovating for Life

Our Value: Integrity, Thankfulness, Professionalism, Progress

Our Vison: To become one of the first–class active pharmaceutical ingredients suppliers and solution platform of API CDMO.

R&D Supports

Chemical Synthesis Institute of Tianjin Hankang Pharma Co.,LTD, Antiviral API R&D Center of Hiray pharma(Jingmen) Co.,LTD

Service Capacity

l Two production bases with a total area about 250,000 m2;

l 9 workshops, including 4 multi-functional workshops, the existing production volume is 103.5m3;

l Adopt modular design and independent TCU temperature control system, equipped with special reaction modules, high and low temperature modules, hydrogenation modules and distillation towers;

l The volume of the reactor is 20L～10000L, the temperature control capacity is -80～220℃, and the hydrogenation design pressure is 10 MPa.

Product Availability

Business Cooperation

● Pharmaceutical Intermediates CDMO;

● API CDMO;

● API supply.